White label ELPA - ClinicalTrials.eu

Title: Evaluation of 68Ga-PSMA-11 PET/MRI and PET/CT Imaging for Treatment Planning in Patients with Intermediate and High-Risk Prostate Cancer

Not recruiting

3 1 1
Investigated drugs:
- Psma-11
Study of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Not recruiting

2 1 1
Investigated diseases:
- B-cell small lymphocytic lymphoma
- Chronic lymphocytic leukaemia
Investigated drugs:
- 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
Study on Atorvastatin for Reducing COPD Exacerbations in Smokers with Chronic Obstructive Pulmonary Disease

Not recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Atorvastatin
Safety Study of Tasimelteon for Treating Non-24-Hour Sleep-Wake Disorder in Blind Individuals Without Light Perception

Not recruiting

3 1 1 1
Investigated drugs:
- Tasimelteon
Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

Not recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Omalizumab
- Mepolizumab
Study on Fecal Microbiota Transplant with Atezolizumab and Bevacizumab for Liver Cancer Patients Unresponsive to Previous Immunotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
- Atezolizumab
- Bevacizumab
Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

Not recruiting

3 1 1
Investigated diseases:
- Medullary thyroid cancer
Investigated drugs:
- Cabozantinib
Study of belantamab mafodotin combined with pomalidomide, dexamethasone, and daratumumab in patients with relapsed/refractory multiple myeloma who previously had 1-3 treatments and are lenalidomide resistant

Not recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

Not recruiting

3 1 1
Investigated diseases:
- Immune thrombocytopenia
Investigated drugs:
- Belimumab
Study of Nimorazole Treatment Based on Hypoxia Profile in Head and Neck Cancer Patients Receiving Radiotherapy with Cisplatin

Not recruiting

3 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Nimorazole
- Cisplatin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies